블로그
-
필라델피아 염색체 양성 급성림프모구백혈병 (Ph+ ALL) 치료 방향
그러나 2000년대 이마티닙(imatinib)과 다사티닙(dasatinib) 같은 표적 치료제인 티로신키나제 억제제(tyrosine kinase, TKI)가 단계적으로 도입되면서 생존율이
- 보로노이 주가 전망::임상 진행 상황은? 세포 내 신호전달을 담당하는 Kinase(인산화효소) 중 질병의 원인이 되.......
- CDK7i 내성극복 Key는 Covalent Bonds Introduction CDK 계열과 암에서의 역할 Cyclin-Dependent Kinase (CDK)는 세포주기 진행과 전사조절에 관여하는 Serine/Threonine 단백질
- CDK7i의 Dual Hit 전략으로 NSCLC와 PDAC 공략 Introduction Cyclin-Dependent Kinase 7(CDK7)은 전사와 세포주기를 동시에 조절하는 핵심 인자이다.
- Cardiovascular, cancer, and infection risks of Janus kinase inhibitors in rheumatoid arthritis ... Abstract Background Evolving evidence suggests that patients undergoing treatment with Janus kinase inhibitors
- A Bayesian network meta-analysis of EGFR-tyrosine kinase inhibitor treatments in patients with ... A Bayesian network meta-analysis of EGFR-tyrosine kinase inhibitor treatments in patients with EGFR mutation-positive have been performed to compare the effectiveness of all epidermal growth factor receptor-tyrosine kinase
- Advances in the mechanism of CDK4/6 inhibitor resistance in HR+/HER2− breast cancer The advent of cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors, which are dependent on cell cycle
- Efficacy of ATR Kinase Inhibitor Elimusertib Monotherapy or Combination in Tumors with DNA Damage... Efficacy of ATR Kinase Inhibitor Elimusertib Monotherapy or Combination in Tumors with DNA Damage Response Pathway and Other Genomic Alterations Abstract The ataxia telangiectasia and RAD3-related (ATR) kinase
- Dual targeting CDK4/6 and CDK7 augments tumor response and anti-tumor immunity in breast cancer... augments tumor response and anti-tumor immunity in breast cancer models Abstract Cyclin-dependent kinase
- A Phase II Study of Fulvestrant plus Abemaciclib in Hormone Receptor–Positive Advanced or ... Advanced or Recurrent Endometrial Cancer Abstract Purpose: Inhibition of the cyclin D–cyclin-dependent kinase We hypothesized that the addition of abemaciclib, a CDK4/6 kinase inhibitor, to antiestrogen therapy.